This is to inform that the Board of Directors of the Company at its meeting held on February 05 2026 has inter alia considered and approved the following agenda:1. Unaudited Financial Results of the Company (Standalone and Consolidated) for the quarterand nine months ended December 31 2025.2. Introduction and adoption of HCG Employee Stock Option Scheme 2026 to grant EmployeeStock Options to Eligible Employees of the Company and its subsidiaries subject to approvalof Members of the Company and other requisite regulatory or statutory approvals as may beapplicable. Detailed disclosure in this regard shall be made separately.3. Appointment of Dr. Naveen R. Nagar as Head - Clinical Strategy and Mr. Pankaj Gautam asChief Information Officer designated as Senior Management Personnel of the Company.Detailed disclosure in this regard shall be made separately.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]